News
Pfizer's inclacumab fails Phase III study for sickle cell disease, disappointing the community while the company remains ...
CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates Entered into ...
TipRanks on MSN4d
CureVac reports Q2 revenue EUR 1.2M vs. EUR 14.4M last year
By entering into a definitive purchase agreement with BioNTech, we intend to unite two highly complementary German companies that are well ...
Eli Lilly has been accused of giving illegal inducements to encourage medical providers in Texas to prescribe its medicines ...
MONTCO Today on MSN6d
WSJ: GSK to Receive $370M in CureVac-BioNTech Vaccine Dispute
Glaxosmithkline, which has major operations in Montgomery County, is set to receive a major settlement, writes Anthony O. Goriainoff for the Wall Street Journal. The pharmaceutical powerhouse will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback